The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis

Schwartz, 1994, Determinants of survival in idiopathic pulmonary fibrosis, Am J Respir Crit Care Med, 149, 450, 10.1164/ajrccm.149.2.8306044

Flaherty, 2003, Clinical-radiographic-pathologic diagnosis in idiopathic interstitial pneumonia, Am J Respir Crit Care Med, 167, A299

King, 2001, Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model, Am J Respir Crit Care Med, 164, 1171, 10.1164/ajrccm.164.7.2003140

Collard, 2003, Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis, Am J Respir Crit Care Med, 168, 538, 10.1164/rccm.200211-1311OC

Latsi, 2003, Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends, Am J Respir Crit Care Med, 168, 531, 10.1164/rccm.200210-1245OC

Perez, 2003, The prognosis of idiopathic pulmonary fibrosis, Am J Respir Cell Mol Biol, 29, S19

Martinez, 2003, Rates and characteristics of death in patients with IPF, Chest, 124, 117S

Mogulkoc, 2001, Pulmonary function in idiopathic pulmonary fibrosis and referral for lung transplantation, Am J Respir Crit Care Med, 164, 103, 10.1164/ajrccm.164.1.2007077

Thomeer, 2004, Interstitial lung diseases: characteristics at diagnosis and mortality risk assessment, Respir Med, 98, 567, 10.1016/j.rmed.2003.10.015

Erbes, 1997, Lung function tests in patients with idiopathic pulmonary fibrosis. Are they helpful for predicting outcome?, Chest, 11, 51, 10.1378/chest.111.1.51

Daniil, 1999, A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis, Am J Respir Crit Care Med, 160, 899, 10.1164/ajrccm.160.3.9903021

Bjoraker, 1998, Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis, Am J Respir Crit Care Med, 157, 199, 10.1164/ajrccm.157.1.9704130

Flaherty, 2003, Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia, Am J Respir Crit Care Med, 168, 543, 10.1164/rccm.200209-1112OC

Wells, 2003, Idiopathic pulmonary fibrosis: a composite index derived from disease extent observed by computed tomography, Am J Respir Crit Care Med, 167, 962, 10.1164/rccm.2111053

King, 2001, Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality, Am J Respir Crit Care Med, 164, 1025, 10.1164/ajrccm.164.6.2001056

Nagao, 2002, Serial evaluation of high-resolution computed tomography findings in patients with idiopathic pulmonary fibrosis in usual interstitial pneumonia, Respiration, 69, 413, 10.1159/000064006

Miyamoto, 2000, Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing, Am J Respir Crit Care Med, 161, 487, 10.1164/ajrccm.161.2.9906015

Eaton, 2005, Six-minute walk, maximal exercise tests: reproducibility in fibrotic interstitial pneumonia, Am J Respir Crit Care Med, 171, 1150, 10.1164/rccm.200405-578OC

Lama, 2003, Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia, Am J Respir Crit Care Med, 168, 1084, 10.1164/rccm.200302-219OC

Hallstrand, 2005, The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis, Eur Respir J, 25, 96, 10.1183/09031936.04.00137203

Mador, 2004, Endurance and strength training in patients with COPD, Chest, 125, 2036, 10.1378/chest.125.6.2036

Miyamoto, 2003, Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing, Am J Respir Crit Care Med, 161, 487, 10.1164/ajrccm.161.2.9906015

Rubin, 2002, The bosentan randomized trial of endothelin antagonist therapy study group, N Engl J Med, 346, 896, 10.1056/NEJMoa012212

2000, Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS), Am J Respir Crit Care Med, 161, 646

Knudson, 1983, Changes in the normal maximal expiratory flow-volume curve with growth and aging, Am Rev Respir Dis, 127, 725

2002, Consensus statement, Am J Respir Crit Care Med, 166, 111, 10.1164/ajrccm.166.1.at1102

King, 2005, Analysis of efficacy end points in a controlled trial of interferon-g1b for idiopathic pulmonary fibrosis, Chest, 127, 171, 10.1378/chest.127.1.171

Greene, 2001, Serum concentrations of surfactant proteins A and D predict mortality in patients with idiopathic pulmonary fibrosis, Chest, 120, S72, 10.1378/chest.120.1_suppl.S72

Greene, 2002, Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis, Eur Respir J, 19, 439, 10.1183/09031936.02.00081102

Gay, 1998, Idiopathic pulmonary fibrosis: predicting response to therapy and survival, Am J Respir Crit Care Med, 157, 1063, 10.1164/ajrccm.157.4.9703022

Nicholson, 2004, Inter-observer variation between pathologists in diffuse parenchymal lung disease, Thorax, 59, 500, 10.1136/thx.2003.011734

Lettieri, 2005, Discordance between general and pulmonary pathologists in the diagnosis of interstitial lung disease, Respir Med, 99, 1425, 10.1016/j.rmed.2005.03.008